Drugs / Ruscus aculeatus L.
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07128979 Comparator | Aug 2025 → Aug 2026 overdue | hemorrhoid | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ruscus aculeatus L. | “The aim of this study was to evaluate the efficacy and safety of Neoven 225 mg capsule containing Ruscus aculeatus L. in individuals with stage II-III hemorrhoidal disease...” NCT07128979 ↗ |
| Known as | Neoven | “The aim of this study was to evaluate the efficacy and safety of Neoven 225 mg capsule containing Ruscus aculeatus L. in individuals with stage II-III hemorrhoidal disease...” NCT07128979 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “R. aculeatus stands out as a traditional phytotherapy agent” NCT07128979 ↗ |
| Route | Oral | “taken orally using one Neoven capsule orally with meals twice a day” NCT07128979 ↗ |